Alnylam Pharmaceuticals
ALNY
ALNY
290 hedge funds and large institutions have $7.7B invested in Alnylam Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 119 increasing their positions, 74 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 290 → 290 (0)
15% less capital invested
Capital invested by funds: $9.06B → $7.7B (-$1.36B)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
290
Holding in Top 10
8
Calls
$74.5M
Puts
$55.5M
Top Buyers
| 1 | +$120M | |
| 2 | +$98.8M | |
| 3 | +$74.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$69.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.7M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$14M | |
| 3 | -$12.5M | |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$9.51M |
| 5 |
T
TOBAM
Paris,
France
|
-$8.34M |